About Us

Rapid mycotoxin testing methods such as lateral flow qualitative test kits and ELISA (enzyme-linked immunosorbent assays) quantitative test kits are the fastest resource for rapid in-house results. But a big hurdle for rapid methods is the ability to process and obtain viable purification of the matrix interferences for a reliable reading of the potential toxin concentration. This is a problem for the end user and manufacturers alike.

Trilogy founders recognized a need in the mycotoxin industry for quick result turn-around using reference methods provided in a quality-focused analytical environment.

So Trilogy began on a mission to reimagine the analytical mycotoxin testing blueprint that laboratories had been following. This included long result wait times, highly expensive cost per analysis, and so much information that was never communicated to the customer. Trilogy founders knew there could be another way to offer analytical services. By starting at the ground up and designing a sample management process that kept the customer in mind through each step. Rapid sample processing is at the heart of Trilogy's mission.  

We also believe that everyone deserves to have the most accurate data available and to be able to understand and successfully interpret the data being supplied to them. Analytical laboratories have a steep hill to climb when it comes to providing analytical results in a way that doesn't need to be deciphered to understand how to make actionable decisions based on what has been given to the customer.

There shouldn't be anything complicated about it. Through relevant resources, education, a consultative environment partnered with a collaborative outlook, our team offers realistic solutions to evolving challenges for our customers.